Boston Scientific (BSX) Invests $1.5B in MiRus for Equity Stake and TAVR Acquisition Option

Boston Scientific Corporation (NYSE:BSX) is one of the oversold tech stocks to buy now. On May 18, Boston Scientific invested $1.5 billion for a 34% equity stake in MiRus LLC, a company specializing in advanced biomaterials and medical implants. The deal includes an exclusive option for Boston Scientific to acquire MiRus’s proprietary TAVR system, which uses a nickel-free rhenium alloy. If specific clinical and regulatory milestones are met, Boston Scientific can complete a full acquisition of the TAVR business for $3 billion.

The SIEGEL TAVR system is currently undergoing the STAR pivotal trial to evaluate its safety and efficacy in treating severe aortic stenosis. The device features an open-cell frame design and is pre-mounted on a delivery sheath that is ~50% smaller than those currently available, aiming to reduce the risk of vascular injury.

Alibaba (BABA), Singapore Tourism Board Partner to Launch "Singapore Street Stars" AI Ranking for Travelers

Pixabay/Public Domain

This partnership is designed to support Boston Scientific Corporation’s (NYSE:BSX) interventional cardiology portfolio by providing a differentiated, less invasive treatment option. Should the option be exercised, the agreement also grants Boston Scientific future rights to acquire additional mitral and tricuspid valve assets from MiRus.

Boston Scientific Corporation (NYSE:BSX) is a medtech company,  incorporated in 1979, that specializes in medical devices for interventional medical specialties. The company’s segments include MedSurg and Cardiovascular.

While we acknowledge the risk and potential of BSX as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and doing so within a shorter time frame. If you are looking for an AI stock that is more promising than BSX and that has 10,000% upside potential, check out our report about the cheapest AI stock.

READ NEXT: 33 Stocks That Should Double in 3 Years and Cathie Wood 2026 Portfolio: 10 Best Stocks to Buy.

Disclosure: None. Follow Insider Monkey on Google News.

1281292 - 11759070 - 1